|
|
|
National Academy of Medical Sciences of Ukraine State Institution "The National Research Center for Radiation Medicine"
|
ISSN 2313-4607 (Online) ISSN 2304-8336 (Print) |
Problems of Radiation Medicine and Radiobiology |
|
|
|
|
|
|
V. G. Bebeshko, K. M. Bruslova, L. O. Lyashenko , N. M. Tsvietkova., L. O. Gonchar, S. G.
Galkina, A. L. Zaitseva, L. S. Reznikova, S. M. Iatsemyrskii, L. O. Tsvet
State Institution «National Research Center for Radiation Medicine of the National Academy of Medical
Sciences of Ukraine», 53 Yuriia Illienka str., Kyiv, 04050, Ukraine
PROGNOSIS OF ACUTE LEUKEMIA DEPENDING ON THE IRON METABOLISM PARAMETERS IN CHILDREN AFTER CHORNOBYL NUCLEAR POWER PLANT ACCIDENT
Objective. To determine the influence of iron metabolism on the prognosis of acute lymphoblastic (ALL) and (AML)
myeloblastic leukemia at the different phases of chemotherapy in children after Chîrnobyl accident.
Materials and methods. 333 children (295 – ALL, 38 – AML) were examined at the stages of chemotherapy. The
comparison group included 93 children without leukemia. Acute leukemia variants, patients survival, relapses, the
nature of disease (live child or died), iron methabolism (morphometric parameters of erythrocytes, SI, SF, STf, TS),
manifestations of dyserythropoiesis, bone marrow sideroblast and patients radiation dose were taken into account.
Results. In 295 patients with ALL the following variants of leukemia were established: pro-B-ALL in 23, «common»
type of ALL in 224, pre-B-ALL in 29, T-ALL in 19. Thirty eight patients were diagnosed with AML (11 – M1, 19 – M2,
8 – M4). Doses of radiation in patients with AL were (2.78 ± 0.10) mSv and they did not correlate with clinical and
hematological parameters, disease variant. Relapse rates and shorter survival were in patients with T-ALL, pro-B-ALL
and AML with SF levels > 500 ng/ml (p < 0.05). The amount of children with normochromic-normocytic anemias and
manifestations of dysplasia of erythroid lineage elements was greater in the AML than in ALL. SF content in patients
was elevated during chemotherapy and was lower than the initial one only in the remission period. Transferrin was
reliably overloaded with iron: TS (70.2 ± 2.3) % compared with the control group (32.7 ± 2.1) %. Correlation
between TS and survival of patients was detected (rs = -0.45). Direct correlation between the number of iron granules in erythrocariocytes and SF level (rs = 0.43) was established, indicating the phenomena of ineffective erythropoiesis.
Conclusions. The negative influence of iron excess in the patients body on the hemopoiesis function, manifestations of ineffective erythropoiesis and the course of acute leukemia in children have been established. Changes in
ferrokinetic processes in children can be the basis of leukemîgenesis development.
Key words: acute leukemia, children, Chornobyl accident, serum iron, ferritin, transferrin, tranferrin saturation, sideroblasts, prognosis.
Problems of Radiation Medicine and Radiobiology. 2020;25:390-401. doi: 10.33145/2304-8336-2020-25-390-401
full text |
1. Sivgin S, Nazlim S, Zararsiz G, Baspinar O, Kaynar L, Deniz K, et al. Increased bone marrow iron scores are strongly correlated with elevated serum ferritin levels and poorer survival in patients with iron overload that underwent allogeneic hematopoietic stem cell transplantation: A single center experience. Clin Lymphoma Myeloma Leuk. 2016;16(10):582-7. DOI: https://doi.org/10.1016/j.clml.2016.08.002
2. Pileggi C, Di Sanzo M, Mascaro V, Marafioti MG, Costanzo FS, Pavia M. Role of serum ferritin level on overall survival in patients with myelodysplastic syndromes: Results of a meta-analysis of observational studies. PLoS One. 2017;12(6):e0179016. DOI: https://doi.org/10.1371/journal.pone.0179016
3. Naoum FA. Iron deficiency in cancer patients. Rev Bras Hematol Hemoter. 2016;38(4):325-30. DOI: https://doi.org/10.1016/j.bjhh.2016.05.009.
4. Patnaik MM, Tefferi A. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification and management. Am J Hematol. 2017;92(3):297-310. DOI: 10.1002/ajh.24637.
5. Panch SR, Yau YY, West K, Diggs K, Sweigart T, Leitman SF. Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload. Transfusion. 2015;55(3):611-22. DOI: 10.1111/trf.12854.
6. Moafi A, Ziaie M, Abedi M, Rahgozar S, Reisi N, Nematollahi P, Moafi H. The relationship between iron bone marrow stores and response to treatment in pediatric acute lymphoblastic leukemia. Medicine (Baltimore). 2017;96(44):e8511. DOI: 10.1097/MD.0000000000008511.
7. Belotti A, Duca L, Borin L, Realini S, Renso R, Parma M, et al.Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications. Leuk Res. 2015;39(1):88-91. DOI: https://doi.org/10.1016/j.leukres.2014.11.003.
8. Sirvent A, Auquier P, Oudin C, Bertrand Y, Bohrer S, Chastagner P, et al. Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study. Bone Marrow Transplant. 2017;52(1):80-7. DOI: 10.1038/bmt.2016.205.
9. Zeidan AM, Giri S, DeVeaux M, Ballas SK, Duong VH. Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes. Ann Hematol. 2019;98(2):339-50. DOI: https://doi.org/10.1007/s00277-018-3539-7.
10. Vardiman JW. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms. Chem Biol Interact. 2010;184(1-2):16-20.
11. Likhtarev IA, editor. [Retrospective-prognosis doses of radiation of the population and general dosimetric certification of 1997 of the settlements of Ukraine, who suffered for radioactive contamination after the Chornobyl accident. Generalized data 1986–1997: Data 7]. Kyiv: Ministry of Health of Ukraine; 1998. 155 p. Ukrainian.
|
|
| |
|
© 2013 Problems of Radiation Medicine |
| | |
|
|